Expected appearance: Clear, colorless solution with no particulates
HELPS INCREASE EXERCISE CAPACITY: The vital energy booster transports long chain fatty acids to the mitochondria to convert them into usable energy
doi: 10.1016/j.amjmed.2009.09.013
Gastrointestinal adverse events Very common (10% or more): Diarrhea (35%), abdominal pain (21%), vomiting (21%), nausea (12%) Common (1% to 10%): Constipation, dyspepsia, gastrointestinal disorder, melena Very rare (less than 0.01%): Abdominal cramps [Ref] Nervous system Very common (10% or more): Headache (37%), dizziness (18%), paresthesia (12%) Common (1% to 10%): Hypertonia, vertigo, taste perversion Frequency not reported : Seizures (with or without pre-existing seizure activity), increase in seizure frequency and/or severity [Ref] Metabolic Very common (10% or more): Hypercalcemia (15%), hypervolemia (12%) Common (1% to 10%): Anorexia, hyperkalemia [Ref] There are reports from clinical trials of significant hypertriglyceridemia associated with high doses of levocarnitine (3 g/day) given to uremic dialysis patients
In the study by Ozturk et al.26, there was a lower incidence of bronchopulmonary incidence in the arm treated with carnitine, though there was no statistical significance
Research is limited, but available evidence suggests: Despite its nickname, berberine works very differently from Ozempic
